The overexpression of Bcl-2 in various cancer cell types, including glioma [6, 13], neuroblasotoma [14], melanoma [15], squamous carcinoma [16], breast [5], lung [17], and colorectal cancer cells [18], increases the migratory and invasive potentials of these cells. Here, BCL2 is linked to squamous cell carcinoma.